Quantum Genomics, a biopharmaceutical research company developing new treatments in the field of cardiovascular diseases,…
Free Market – Alternext: Quantum Genomics passes a new milestone
Listed on the open market since the summer of 2009, Quantum Genomics has just transferred…
Quantum Genomics transfers its shares to Alternext Paris as of April 10, 2014, following a capital increase of €3.4 million
Quantum Genomics, a biopharmaceutical research company developing new treatments in the field of cardiovascular diseases,…
Quantum Genomics announces the establishment of a liquidity contract with Aurel BGC
Quantum Genomics today announced the implementation of a liquidity contract with Aurel BGC. By contract…
Signing of a collaboration agreement with a major company in the field of animal health.
Quantum Genomics, a biopharmaceutical research company developing new treatments in the field of cardiovascular diseases,…
ANR provides a grant of € 1 million for the implementation of a research program with the QGC001
Quantum Genomics, a biopharmaceutical research company developing new treatments in the field of cardiovascular diseases,…